BeOne Medicines (ONC) Other Operating Expenses (2017 - 2023)

BeOne Medicines (ONC) has 7 years of Other Operating Expenses data on file, last reported at $188000.0 in Q2 2023.

• Quarterly Other Operating Expenses fell 99.74% year-over-year to $188000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $188000.0 (up 100.29% YoY) and the FY2020 annual result came in at $71.5 million, down 1.4% from the prior year.
• Other Operating Expenses improved to $188000.0 in Q2 2023 per ONC's latest filing, from $187000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $76.7 million in Q3 2022 and bottomed at -$213.5 million in Q4 2022.
• The 5-year median for Other Operating Expenses is $19.4 million (2019), against an average of $8.0 million.
• The widest annual swing landed in 2019, when Other Operating Expenses jumped 229.08%; it then sank 649.82% in 2021.
• Tracing ONC's Other Operating Expenses over 5 years: stood at $18.3 million in 2019, then advanced by 16.11% to $21.3 million in 2020, then slumped by 649.82% to -$116.9 million in 2021, then sank by 82.61% to -$213.5 million in 2022, then surged by 100.09% to $188000.0 in 2023.
• Per Business Quant, the three latest ONC Other Operating Expenses figures stand at $188000.0 (Q2 2023), $187000.0 (Q1 2023), and -$213.5 million (Q4 2022).

Peer Comparison